Form 8-K - Current report:
SEC Accession No. 0001104659-25-058525
Filing Date
2025-06-11
Accepted
2025-06-11 16:02:53
Documents
13
Period of Report
2025-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517563d2_8k.htm   iXBRL 8-K 52042
2 EXHIBIT 3.1 tm2517563d2_ex3-1.htm EX-3.1 7799
  Complete submission text file 0001104659-25-058525.txt   231987

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocul-20250611.xsd EX-101.SCH 3005
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20250611_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20250611_pre.xml EX-101.PRE 22352
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2517563d2_8k_htm.xml XML 3681
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36554 | Film No.: 251039897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)